This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Insulin » Research

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Investigational Januvia (MSD) Put Through Its Paces for Diabetes

Posted: Thursday, June 15, 2006

Researchers reported that, Januvia (sitagliptin), an investigational oral agent for type 2 diabetes, appears to be effective when given as a monotherapy or as an adjunct to Glucophage (metformin) or Actos (pioglitazone). FDA approval expected soon.

New Oral Insulin Shows Safety, Feasibility in Trials

Posted: Thursday, June 15, 2006

In the first human trials of oral insulin, the drug acted within 15 minutes and showed 60%-70% of the biopotency of injected insulin, without causing any adverse effects, researchers reported here at the 66th Scientific Sessions of the American Diabetes Association.

Scientists Make Major Finding on Potential Cure for Type 1 Diabetes

Posted: Monday, May 15, 2006

The study, which combined two therapies (anti-CD3 antibody and proinsulin peptide) already being tested individually in human clinical trials, produced better efficacy, longer-lasting results and fewer side effects in the preclinical trials in mice than either therapy has shown alone in the human studies. The researchers hope to begin testing the combination therapy in human clinical trials later this year.

Dynamic Duo, Combination Therapy Reverses Type 1 Diabetes

Posted: Monday, May 15, 2006

By combining an oral with an intranasal therapy for type 1 diabetes that have individually shown beneficial, but limited, effects in previous studies, Matthias von Herrath and colleagues at the La Jolla Institute for Allergy and Immunology deliver a one-two punch, and prove that, in this case, 2 treatments work together better than one.

Intensive Insulin Beneficial For Those With Long ICU Stays

Posted: Thursday, April 27, 2006

Intensive insulin therapy administered from admission onwards in patients in the medical intensive care unit reduced morbidity among all patients and mortality among those who remained in the ICU for at least a third day.

Intensive Insulin Beneficial For Those With Long ICU Stays

Posted: Thursday, April 27, 2006

Intensive insulin therapy administered from admission onwards in patients in the medical intensive care unit reduced morbidity among all patients and mortality among those who remained in the ICU for at least a third day.

Little Difference Between Human Insulin And Analogs

Posted: Thursday, April 27, 2006

Fast-acting artificial insulin drugs work just as well as regular human insulin, but it’s unclear how they could affect the health of people with diabetes over the long run.

Seaweed Bubbles May Fight Diabetes

Posted: Thursday, March 16, 2006

Encapsulating insulin producing cells in tiny seaweed bubbles and injecting them into people with type1 diabetes could one day remove the need for daily insulin injections.

Insulin Glargine A True 24 Hour Insulin, Maybe Not!

Posted: Thursday, February 09, 2006

What is the optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at mealtimes?

Evidence Supports First Non-Injectable Insulin as Alternative Treatment for Diabetes

Posted: Thursday, December 08, 2005

The article nevertheless concludes that “current evidence suggests that Exubera is an alternative to short-acting subcutaneous insulin therapy providing a further choice for the treatment of patients with type 1 or type 2 diabetes,” and that “a major benefit of Exubera…appears to be the improvement in patient treatment satisfaction which is related to its ease of use, leading to better adherence to treatment.”

Caution: the first week that Exubera is released, you will need to stay off the roads!